EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype

Bhavishya Ramamoorthy, Naris Nilubol

Surgical Oncology Clinics of North America · 2023

DOI: 10.1016/j.soc.2022.10.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Surgical Oncology Clinics of North America, 2023. Verfasst von Bhavishya Ramamoorthy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Oncology Program, Endocrine Surgery Section, National Cancer Institute, NIH, 10 Center Drive, Building 10 - Room 45952, Bethesda, MD 20892, …. Hauptthemen laut MEDLINE: Multiple Endocrine Neoplasia Type 1, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors, Pancreatic Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, National Cancer Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple endocrine neoplasia type 1 syndrome (MEN1) is a disease caused by mutations in the MEN1 tumor suppressor gene leading to hyperparathyroidism, pituitary adenomas, and entero-pancreatic neuroendocrine tumors. Pancreatic neuroendocrine tumors (PNETs) are a major cause of mortality in patients with MEN1. Identification of consistent genotype-phenotype correlations has remained elusive, but MEN1 mutations in exons 2, 9, and 10 may be associated with metastatic PNETs; patients with these mutations may benefit from more intensive surveillance and aggressive treatment. In addition, epigenetic differences between MEN1-associated PNETs and sporadic PNETs are beginning to emerge, but further investigation is required to establish clear phenotypic associations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple Endocrine Neoplasia Type 1Neuroectodermal Tumors, PrimitiveNeuroendocrine TumorsPancreatic NeoplasmsHumansGenotypePhenotypeProto-Oncogene Proteins

Stichwörter der Autor:innen

EpigeneticGenotypeMeninMultiple endocrine neoplasia type 1 syndrome (MEN1)Pancreatic neuroendocrine tumor (PNET)Phenotype

Substanzen

MEN1 protein, humanProto-Oncogene Proteins

Autor:innen und Institutionen

  • Surgical Oncology Program, Endocrine Surgery Section, National Cancer Institute, NIH, 10 Center Drive, Building 10 - Room 45952, Bethesda, MD 20892, USA.
  • Surgical Oncology Program, Endocrine Surgery Section, National Cancer Institute, NIH, 10 Center Drive, Building 10 - Room 45952, Bethesda, MD 20892, USA. Electronic address: naris.nilubol@nih.gov.

Förderung

  • Intramural NIH HHS
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Ramamoorthy, B., & Nilubol, N. (2023). Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype. Surgical Oncology Clinics of North America. https://doi.org/10.1016/j.soc.2022.10.008

Vancouver

Ramamoorthy B, Nilubol N. Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype. Surgical Oncology Clinics of North America. 2023. doi:10.1016/j.soc.2022.10.008

BibTeX
@article{Ramamoorthy2023,
  author = {Ramamoorthy, Bhavishya and Nilubol, Naris},
  title = {Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype},
  journal = {Surgical Oncology Clinics of North America},
  year = {2023},
  doi = {10.1016/j.soc.2022.10.008}
}
Kostenlos starten →